ArticleBMJ open2020

Efficacy and safety of exogenous surfactant therapy in patients under 12 months of age invasively ventilated for severe bronchiolitis (SURFABRON): protocol for a multicentre, randomised, double-blind, controlled, non-profit trial.

Paolo Biban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.